Subscribe to Newsletter

OncoDNA

OncoDNA is an oncology-focused healthcare technology company that combines advanced, comprehensive testing of all clinically relevant cancer biomarkers (DNA, RNA and protein profiles) from both solid and liquid biopsies with a proprietary cancer treatment knowledge database which continuously ‘learns’ from cutting-edge, validated, scientific and medical advances. This one-stop-shop analysis and interpretation service gives oncologists actionable results to enable the selection of treatments tailored to the individual patient’s cancer profile. For laboratories worldwide with NGS facilities who would like to reach the same level of expertise, we provide them with state-of-the-art interpretation software to improve their oncology-oriented analyses routine work.

Contact Information:

OncoDNA S.A,
Rue Louis Breguet 1,
6041 Gosselies,
Belgium
+32 (0) 71 18 35 00
[email protected]
www.oncodna.com

Content by OncoDNA:

OncoKDM Lite: Improving TSO500 data interpretation accuracy from VCF files in oncology routine practice

| Contributed by OncoDNA

This app note aims to demonstrate how labs can streamline large panels (TSO500) NGS interpretation.

OncoKDM Lite – The Clinical Decision Support for oncology to interpret NGS data

| Contributed by OncoDNA

OncoKDM Lite interprets tumor-based NGS data to guide oncologists in their treatment decision making.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register